Elizabeth Smyth

1993–2025 年に発表

105
論文数
21,949
被引用数
50
h 指数
92
i10 指数

被引用数

Elizabeth Smyth の年別被引用数1994 年: 被引用 6 件1995 年: 被引用 12 件1996 年: 被引用 11 件1997 年: 被引用 7 件1998 年: 被引用 20 件1999 年: 被引用 16 件2000 年: 被引用 22 件2001 年: 被引用 16 件2002 年: 被引用 24 件2003 年: 被引用 16 件2004 年: 被引用 27 件2005 年: 被引用 25 件2006 年: 被引用 32 件2007 年: 被引用 35 件2008 年: 被引用 18 件2009 年: 被引用 13 件2010 年: 被引用 24 件2011 年: 被引用 14 件2012 年: 被引用 18 件2013 年: 被引用 12 件2014 年: 被引用 25 件2015 年: 被引用 20 件2016 年: 被引用 28 件2017 年: 被引用 62 件2018 年: 被引用 107 件2019 年: 被引用 482 件2020 年: 被引用 671 件2021 年: 被引用 999 件2022 年: 被引用 969 件2023 年: 被引用 818 件2024 年: 被引用 1,586 件2025 年: 被引用 742 件2026 年: 被引用 25 件

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 2,641 件、この内訳の 28.2%アメリカ合衆国: 引用元論文 1,329 件、この内訳の 14.2%イギリス: 引用元論文 586 件、この内訳の 6.2%日本: 引用元論文 435 件、この内訳の 4.6%イタリア: 引用元論文 430 件、この内訳の 4.6%ドイツ: 引用元論文 425 件、この内訳の 4.5%オランダ: 引用元論文 358 件、この内訳の 3.8%韓国: 引用元論文 260 件、この内訳の 2.8%フランス: 引用元論文 233 件、この内訳の 2.5%スペイン: 引用元論文 208 件、この内訳の 2.2%オーストラリア: 引用元論文 198 件、この内訳の 2.1%カナダ: 引用元論文 186 件、この内訳の 2%
0%28.2%その他 22.3%

分野

  • Medicine61%
  • Biochemistry, Genetics and Molecular Biology28.9%
  • Engineering3.1%
  • Immunology and Microbiology2.8%
  • Neuroscience0.9%
  • Health Professions0.5%
  • その他2.8%

トピック

  • Gastric Cancer Management and Outcomes8%
  • Esophageal Cancer Research and Treatment5.6%
  • Cancer Cells and Metastasis4.5%
  • Cancer Immunotherapy and Biomarkers4%
  • Cancer Genomics and Diagnostics2.9%
  • Gastrointestinal Tumor Research and Treatment2.4%
  • その他72.6%

共著者

全論文

検索で開く
  1. Gastric cancer

    著者: , , , , - The Lancet 2020 被引用: 4,853

  2. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mitch Dowsett, Johann S. de Bono, Paul Workman, Anguraj Sadanandam, Matteo Fassan, Owen J. Sansom, Suzanne A. Eccles, Naureen Starling, Chiara Braconi, Andrea Sottoriva, Simon P. Robinson, David Cunningham, Nicola Valeri - Science 2018 被引用: 2,131

  3. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    著者: , , , , , , , - Annals of Oncology 2022 被引用: 1,382

  4. Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    著者: , , , , , , , , - Annals of Oncology 2022 被引用: 656

  5. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study

    著者: , , , , , , , , , , , , , , , - The Lancet Oncology 2023 被引用: 242

  6. Oesophageal cancer

    著者: , , , , , , - Nature Reviews Disease Primers 2017 被引用: 1,078

  7. Oesophageal cancer

    著者: , , , - The Lancet 2017 被引用: 1,158

  8. Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 474

  9. Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 202

  10. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    著者: , , , , , - Annals of Oncology 2016 被引用: 1,595

  11. Mismatch Repair Deficiency, Microsatellite Instability, and Survival

    著者: , , , , , , , , , , , , , , , - JAMA Oncology 2017 被引用: 521

  12. Low Programmed Death-Ligand 1–Expressing Subgroup Outcomes of First-Line Immune Checkpoint Inhibitors in Gastric or Esophageal Adenocarcinoma

    著者: , , , , , , , , - Journal of Clinical Oncology 2021 被引用: 180

  13. Colorectal liver metastases: Current management and future perspectives

    著者: , , , , , , , , , , , , , , - World Journal of Clinical Oncology 2020 被引用: 262

  14. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chikashi Ishioka, Elizabeth Smyth - ESMO Open 2024 被引用: 90

  15. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2018 被引用: 288

  16. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2018 被引用: 221

  17. Longitudinal tracking of 97 esophageal adenocarcinomas using liquid biopsy sampling

    著者: , , , , , , , , , , , , , , - Annals of Oncology 2021 被引用: 106

  18. Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 305

  19. High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2016 被引用: 276

  20. Non-invasive diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis

    著者: , , , , , , , , , - Clinical Microbiology and Infection 2021 被引用: 72

  21. Job satisfaction and career intentions of registered nurses in primary health care: an integrative review

    著者: , , - BMC Family Practice 2018 被引用: 195

  22. Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark I. van Berge Henegouwen, Maarten C.C.M. Hulshof, Jolanda van Dieren, Marieke A. Vollebergh, Johanna W. van Sandick, Paul M. Jeene, C.T. Muijs, Marije Slingerland, Francine E.M. Voncken, Henk H. Hartgrink, Geert-Jan Creemers, Maurice J.C. van der Sangen, Grard A. P. Nieuwenhuijzen, Maaike Berbée, Marcel Verheij, Bas P. L. Wijnhoven, Laurens V. Beerepoot, Nadia Haj Mohammad, Stella Mook, Jelle P. Ruurda, Piotr Kołodziejczyk, Wojciech Polkowski, Lucjan Wyrwicz, María Alsina, Manuel Pera, Tania Fleitas, Andrés Cervantes, Magnus Nilsson, Stefan Mönig, Dorothea Wagner, Matthias Gückenberger, Ewen A. Griffiths, Elizabeth Smyth, George B. Hanna, Sheraz R. Markar, M. Asif Chaudry, M. Hawkins, Edward Cheong, Richard van Hillegersberg, Peter S.N. van Rossum, Tom Rozema, Joos Heisterkamp, Markus Schaefer, E.M. Ozsahin, Jacco J. de Haan, Jan Willem van den Berg, Frédéric Duprez, Eduard Callebout, Elke Van Daele, Ulrich Hacker, Albrecht Hoffmeister, Thomas Kuhnt, Timm Denecke, Regine Kluge, Gerald W. Prager, Aysegül Ilhan‐Mutlu, Dajana Cuicchi, Andrea Ardizzoni, Camiel Rosman, Elske C. Gootjes, Heidi Rütten, Francesco Puccetti, Stefano Cascinu, N. Slim, Maria Eugenia Barrios, Maria Carmen Fernandez, Roberto Martí-Oriol, Marisol Huerta Alvaro, Almudena Vera, E. Jordá ほか 10 名 - European Journal of Cancer 2023 被引用: 53

  23. Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dirk De Ruysscher, Elisabeth G.E. de Vries, Rebecca Dent, Jean-Yves Douillard, Domenico D’Ugo, Rafał Dziadziuszko, Corinne Faivre‐Finn, Eudald Felip, M.C. Garassino, Pilar Garrido, Nicolas Girard, Rob Glynne‐Jones, V. Golfinopoulos, John B.A.G. Haanen, E. Hamilton, Pasi A. Jänne, Karin Jordan, Ravindran Kanesvaran, S.B. Kim, Uwe G. Liebert, F. Lordick, Jean-Pascal Machiels, Olivier Michielin, T.S.K. Mok, Gilberto Morgan, Radka Obermannová, K. Park, Antonio Passaro, George Pentheroudakis, Solange Peters, Martin Reck, Romane Soler, Florian Scotté, Suresh Senan, Cristiana Sessa, Elizabeth Smyth, Ross A. Soo, Jean‐Charles Soria, Jennifer O. Spicer, Florian Strasser, Josep Tabernero, Dongling Tan, Dario Trapani, Eric Van Cutsem, Henk van Halteren, Paul E. Van Schil, Giulia Veronesi, Jing Yang, Giulia Veronesi, Jing Yang - Annals of Oncology 2020 被引用: 313

  24. Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial

    著者: , , , , , , , , , , , , , , , , , - The Lancet Oncology 2017 被引用: 288